TCON - TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q3 2021 Results - Earnings Call Transcript
TRACON Pharmaceuticals, Inc. (TCON) Q3 2021 Earnings Conference Call November 03, 2021 4:30 PM ET Company Participants Charles Theuer - President and Chief Executive Officer Scott Brown - Chief Financial Officer Conference Call Participants Nicholas Abbott - Wells Fargo Maurice Raycroft - Jefferies Edward White - H.C. Wainwright Robert Hazlett - BTIG Presentation Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Third Quarter 2021 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers' prepared remarks, we will conduct a question-and-answer session and instructions will be given at that time. During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway in our development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and
For further details see:
TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q3 2021 Results - Earnings Call Transcript